Endo USA Inc., a Keenova Therapeutics Company
Endo USA Inc., a Keenova Therapeutics Company
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Mycophenolate Pregnancy Registry | autoimmune disease, immune system disorder | Recruiting | Not stated | 2026-10-06 | NCT01733082 | |
| Study to Assess the Long-term Safety of KN3835 in the Treatment and Retreatment of Flexible/Semi-Flexible Hammertoe (HMT) | Flexible Hammertoe; Semi-flexible Hammertoe | Not yet recruiting | Phase 3 | 2026-09-29 | NCT07846280 | |
| Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT) | Flexible Hammertoe; Semi-flexible Hammertoe | Recruiting | Phase 3 | 2026-09-14 | NCT07759362 | |
| Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease | Genital Diseases, Male Urogenital Diseases, Peyronie disease, Skin and Connective Tissue Diseases, Urogenital Diseases, connective tissue disorder, male reproductive system disorder, penile disorder | Active, not recruiting | Phase 4 | 2026-08-26 | NCT06649539 | |
| Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's | Genital Diseases, Male Urogenital Diseases, Peyronie disease, Skin and Connective Tissue Diseases, Surgical Wound, Urogenital Diseases, connective tissue disorder, injury, male reproductive system disorder, penile disorder | Active, not recruiting | Phase 4 | 2026-08-26 | NCT04786106 | |
| Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease | Genital Diseases, Male Urogenital Diseases, Peyronie disease, Sexual Dysfunctions, Psychological, Skin and Connective Tissue Diseases, Urogenital Diseases, connective tissue disorder, male reproductive system disorder, penile disorder, psychiatric disorder | Active, not recruiting | Phase 4 | 2026-06-04 | NCT05777031 |